www.biospace.com

• equiv: origin-trial content: A7vZI3v+Gz7JfuRolKNM4Aff6zaGuT7X0mf3wtoZTnKv6497cVMnhy03KDqX7kBz/q/iidW7srW31oQbBt4VhgoAAACUeyJvcmlnaW4iOiJodHRwczovL3d3dy5nb29nbGUuY29tOjQ0MyIsImZlYXR1cmUiOiJEaXNhYmxlVGhpcmRQYXJ0eVN0b3JhZ2VQYXJ0aXRpb25pbmczIiwiZXhwaXJ5IjoxNzU3OTgwODAwLCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==
• charset: UTF-8
• property: og:url content: https://www.biospace.com/
• property: og:image content: https://static.biospace.com/dims4/default/d32393a/2147483647/strip/true/crop/1120x630+40+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F88%2Fa9fddaf440db946b77e1d45d2e26%2Fbiospace-5.png
• property: og:image:url content: https://static.biospace.com/dims4/default/d32393a/2147483647/strip/true/crop/1120x630+40+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F88%2Fa9fddaf440db946b77e1d45d2e26%2Fbiospace-5.png
• property: og:image:width content: 1440
• property: og:image:height content: 810
• property: og:image:type content: image/png
• property: og:site_name content: BioSpace
• property: og:type content: website
• name: twitter:card content: summary_large_image
• name: twitter:site content: @biospace
• property: fb:app_id content: 2120989681618413
• name: viewport content: width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=5
• name: brightspot.contentId content: 0000018c-6551-dbde-a9dd-e55f20fc0000
• equiv: origin-trial content: AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==
• equiv: origin-trial content: Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==
• equiv: origin-trial content: A9nrunKdU5m96PSN1XsSGr3qOP0lvPFUB2AiAylCDlN5DTl17uDFkpQuHj1AFtgWLxpLaiBZuhrtb2WOu7ofHwEAAACKeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9
• equiv: origin-trial content: A93bovR+QVXNx2/38qDbmeYYf1wdte9EO37K9eMq3r+541qo0byhYU899BhPB7Cv9QqD7wIbR1B6OAc9kEfYCA4AAACQeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9
• equiv: origin-trial content: A1S5fojrAunSDrFbD8OfGmFHdRFZymSM/1ss3G+NEttCLfHkXvlcF6LGLH8Mo5PakLO1sCASXU1/gQf6XGuTBgwAAACQeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9

• Cross-domain consent
• https://www.biospace.com/privacy-policy/
• www.biospace.com
• https://www.biospace.com/news
• https://www.biospace.com/drug-development
• FDA
• https://www.biospace.com/drug-delivery
• Deals
• Insights
• Job Trends
• https://www.biospace.com/cell-and-gene-therapy
• https://www.biospace.com/cancer
• Opinion
• https://www.biospace.com/search-press-releases
• https://www.biospace.com/latest-news-press-releases
• https://www.biospace.com/podcasts
• https://www.biospace.com/events
• https://www.biospace.com/companies
• https://www.biospace.com/hotbeds
• https://www.biospace.com/reports
• https://www.biospace.com/career-advice
• https://www.biospace.com/nextgen
• https://www.biospace.com/biospace-40-under-40
• https://www.biospace.com/best-places-to-work
• https://www.biospace.com/employer-resources
• https://www.biospace.com/advertise
• https://www.biospace.com/talent-solutions
• https://www.biospace.com/press-release-solutions
• https://www.biospace.com/subscribe-to-newsletters
• http://www.biospace.com/
• http://www.biospace.com/#container-module-2-column-e50011
• http://www.biospace.com/#list-module-e50007
• It’s Official: FDA Will Now Default to One Clinical Trial for Drug Applications
• Regulatory
• Tristan Manalac
• Cassidy Names Areas of Improvement for FDA’s Regulatory ‘Black Box’
• Government
• Novartis Bets Up to $1.7B in Cardio-Focused Peptide Partnership
• Collaboration
• J&J Plans $1B Investment in PA Cell Therapy Manufacturing Facility
• Manufacturing
• Nick Paul Taylor
• 9 Companies Hiring Now in Pennsylvania
• Angela Gabriel
• Muscle Preservation, Tolerability and Alternative Administration Routes Define Obesity’s Drug Future
• Insights
• Jennifer Smith-Parker
• NIH’s Jay Bhattacharya Steps In as Acting CDC Chief
• CDC
• Annalee Armstrong
• FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision
• Heather McKenzie
• Korsana Joins Alzheimer’s Amyloid Arena With $150M Debut, Next-Gen Antibody
• Alzheimer’s disease
• http://www.biospace.com/#featured-stories
• Extending Scientific Rigor From Bench to Boardroom
• Oded Ben-Joseph
• Disc’s FDA Rejection Raises Questions About Commissioner’s Vouchers
• Dan Samorodnitsky
• How DIA Is Helping Regulators Turn AI Principles into Everyday Review Practice
• Sponsored
• Early-Stage Biotechs Suffer in 2025 As VC Shuns Risk: PitchBook
• Venture capital
• Ionis Paves Its Own Path as Initial Tryngolza Launch Defies Expectations
• Rare diseases
• Ongoing Regulatory Uncertainty Means Innovation Is Now Higher Risk
• Harris Kaplan
• Load More
• http://www.biospace.com/#logo-list-module-540000
• https://www.biospace.com/employer/551538/frederick-national-laboratory-for-cancer-research
• https://www.biospace.com/employer/401200/afton-scientific-llc
• https://www.biospace.com/employer/397715/syngene-international-ltd
• https://www.biospace.com/employer/397613/moderna-inc
• https://www.biospace.com/employer/400681/lundbeck
• https://www.biospace.com/employer/1959841/united-states-pharmacopeia
• https://www.biospace.com/employer/400440/adicet-bio-inc
• https://www.biospace.com/employer/548265/daiichi-sankyo
• https://www.biospace.com/employer/2038633/maze-therapeutics
• https://www.biospace.com/employer/2994566/protara-therapeutics
• https://www.biospace.com/employer/401185/recursion
• https://www.biospace.com/employer/399574/4d-molecular-therapeutics
• https://www.biospace.com/employer/395010/eli-lilly-and-company
• https://www.biospace.com/employer/544924/reflexion
• https://www.biospace.com/employer/537761/modex-therapeutics
• https://www.biospace.com/employer/247841/biomarin-pharmaceutical-inc
• https://www.biospace.com/employer/395032/regeneron-pharmaceuticals-inc
• https://www.biospace.com/employer/2275294/day-one-biopharmaceuticals
• https://www.biospace.com/employer/1962054/eyepoint
• https://www.biospace.com/employer/545568/novo-nordisk
• https://www.biospace.com/employer/544352/catalyst-pharmaceuticals-inc
• https://www.biospace.com/employer/2347028/dren-bio
• https://www.biospace.com/employer/2186227/formation-bio
• https://www.biospace.com/employer/248580/santen-inc
• https://www.biospace.com/employer/521396/csl
• https://www.biospace.com/employer/401082/takeda
• https://www.biospace.com/employer/397417/nurix-therapeutics
• https://www.biospace.com/employer/536200/adma-biologics
• https://www.biospace.com/employer/2813365/sonothera
• https://www.biospace.com/employer/519815/cmic-inc
• https://www.biospace.com/employer/2076556/mammoth-biosciences
• https://www.biospace.com/employer/2605066/syner-g-biopharma-group
• https://www.biospace.com/employer/247739/amgen
• https://www.biospace.com/employer/539922/arvinas-inc
• https://www.biospace.com/employer/399503/genscript
• https://www.biospace.com/employer/2812917/apogee-therapeutics
• https://www.biospace.com/employer/2954657/marea-therapeutics
• https://www.biospace.com/employer/399645/ideaya-biosciences
• https://www.biospace.com/employer/394752/anaptysbio-inc
• https://www.biospace.com/employer/2206124/terray-therapeutics
• https://www.biospace.com/employer/248221/jazz-pharmaceuticals-inc
• https://www.biospace.com/employer/2820432/dyne-therapeutics
• https://www.biospace.com/employer/2455534/alumis-inc
• https://www.biospace.com/employer/247738/atcc
• https://www.biospace.com/employer/2216621/invitro-cell-research-llc
• https://www.biospace.com/employer/2186310/civica-rx
• https://www.biospace.com/employer/539128/ocugen-inc
• https://www.biospace.com/employer/398177/insmed-incorporated
• https://www.biospace.com/employer/542037/intellia-therapeutics
• https://www.biospace.com/employer/548162/visterra-inc
• https://www.biospace.com/employer/549539/legend-biotech
• https://www.biospace.com/employer/2881096/mirador-therapeutics-inc
• https://www.biospace.com/employer/2964442/eagle-analytical
• https://www.biospace.com/employer/509467/tris-pharma
• https://www.biospace.com/employer/400281/grail-inc
• https://www.biospace.com/employer/2491224/acrivon-therapeutics
• https://www.biospace.com/employer/397714/abbvie
• https://www.biospace.com/employer/2463901/resilience
• http://www.biospace.com/#from-biospace-insights
• http://www.biospace.com/#list-module-9d0000
• HER2’s Digital Rebirth Is Unlocking the Full Potential of ADCs
• From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
• Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
• http://www.biospace.com/#event-list-module-5c0000
• Register: Lean Derisking: Taking Your Proof of Concept to the Clinic
• Better Together: A Pharma & Biotech EHS Forum
• [Webinar] In Vitro Assays for ADC Discovery: From Assay Design to Translational Insights
• Register: The Future is Collaborative: Transforming Clinical Trials
• Medical Affairs and Scientific Communications Forum
• http://www.biospace.com/#listen
• Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
• As FDA Moves Away From Animal Testing, AI and Organoids Can Shine
• Jef Akst
• Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
• Load More
• http://www.biospace.com/#job-trends
• Concerto Downsizes Amid Pivot to Consumers; Faraday Closes Down
• BioSpace Editorial Staff
• 8 Things Job Candidates Say—or Don’t Say—That Turn Hiring Managers Off
• 2025 Q4 Job Market Report: Positive Signs Emerge for Job Seekers
• 7 Key Insights Into the 2026 Job Market and Hiring Landscape
• Hiring Outlook: January Brings Year-Over-Year Layoff Decline
• http://www.biospace.com/#subscribe-to-genepool
• http://www.biospace.com/#special-editions
• Deep Dive: Huntington’s at a Crossroads
• Neuroscience
• Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
• Special edition
• Deep Dive: Oral Obesity Drugs on the Cusp
• Cardiovascular disease
• Load More
• http://www.biospace.com/#container-module-3-column-ea000f
• http://www.biospace.com/#partnerships-alliances
• Lilly Fronts $100M for CSL’s IL-6 Blocker to Bolster I&I, Cardiovascular Pipeline
• Madrigal Dives Further Into MASH With up to $4.4B siRNA Deal With Chinese Biotech
• MASH
• Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
• Mergers & acquisitions
• Programmable RNA 2.0: Beyond the First mRNA Revolution
• Roche Keeps the Deals Coming With up to $1.7B SangeneBio RNAi Pact
• http://www.biospace.com/#bankruptcies
• Lilly Prepares $1B+ Orforglipron Stock Ahead of Approval as Novo Brings Wegovy Pill Overseas
• Obesity
• Oral Wegovy Brings in Thousands of New GLP-1 Patients
• GLP-1
• Weight Loss Drama Compounds on Heels of Novo, Lilly Earnings, Plus Gene Therapy News
• Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
• AstraZeneca Teases ‘Very Competitive’ Weight-Loss Pill—But Stays Mum on Details
• Earnings
• http://www.biospace.com/#earnings-reports
• Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus
• Legal
• CDC Left Leaderless Again After Acting Director Departs HHS
• 2026 Could Mark a Turning Point for American Innovation
• John Stanford
• HHS Backs Prasad Amid Moderna Flu Shot Blowback
• AbbVie Sues HHS, CMS for Including Botox in Drug Price Negotiation Program
• http://www.biospace.com/#career-hub
• When Senior Leaders Are Asked To Carry Too Much
• Michael Pietrack
• 9 Companies Hiring in Boston
• Webinar: 2026 Hiring Trends and Job Market Signals
• BioSpace Insights
• The Top 12 Companies Hiring in Biopharma Now
• Subtraction Before Addition: A Smarter Way To Set and Execute Goals
• Angela Justice
• Going With the Flow: Finding Success in Academic and Biotech Research Cultures
• Manali Shah
• JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
• The Four Employment Agreement Questions Every Pharma Executive Must Ask
• Leadership
• 9 Companies Hiring in New Jersey
• Chantal Dresner
• http://www.biospace.com/#list-module-ec0000
• Biotech Bay
• Biotech Beach
• Genetown
• Pharm Country
• BioMidwest
• BioForest
• BioCapital
• Bio NC
• Lone Star Bio
• http://www.biospace.com/#container-module-2-column-a70000
• http://www.biospace.com/#best-places-to-work
• http://www.biospace.com/#in-case-you-missed-it
• Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
• Vaccines
• FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad’s Skepticism
• Complete response letters
• ‘Just Agree to It:’ Pazdur Said He Was Told To Cosign FDA’s Reduced Trial Requirements
• http://www.biospace.com/#reports
• Report: 2025 Employment Outlook
• Report: 2025 U.S. Life Sciences Salary Report
• Report: The State of Diversity, Equity, Inclusion and Belonging in Life Sciences
• Load More
• http://www.biospace.com/#container-module-3-column-5a000f
• http://www.biospace.com/#money
• Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand
• Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy
• Pipeline
• AbbVie’s I&I Portfolio Sells $30 Billion but Execs Again Underline Other Areas
• Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline
• http://www.biospace.com/#regulatory
• Compass’ Psychedelic Shows Durability ‘In Spades’ as Path to FDA Clears
• Psychedelics
• Biogen’s Much Anticipated Tau Readout in Alzheimer’s Will Spur More Questions
• Ultragenyx’s Gene Therapy Shows Long-Term Efficacy in Two Sanfilippo Studies
• Gene therapy
• AbbVie CSO Touts ‘Breakthrough Type Therapy’ Psychedelic as J&J’s Spravato Keeps Growing
• http://www.biospace.com/#policy
• Moderna’s mRNA Vaccine Refusal Comes Amid Global Advanced Therapies Push
• Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp
• Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
• BioMarin Bet on Amicus To Ease Voxzogo’s Decline. Will It Work?
• In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego
• http://www.biospace.com/#promo-module-7e0000
• http://www.biospace.com/#html-embed-module-5d0000
• https://www.biospace.com/webinars
• https://www.biospace.com/archive
• https://www.biospace.com/about-us
• https://www.biospace.com/editorial
• https://www.biospace.com/join-our-team
• https://www.biospace.com/contact-us
• https://www.biospace.com/terms-and-conditions
• https://www.biospace.com/privacy-policy
• https://www.biospace.com/rss-feeds

• https://www.cookiebot.com/en/what-is-behind-powered-by-cookiebot/?utm_source=banner_cb&utm_medium=referral&utm_content=v2
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• Learn more about this provider
• jobs.biospace.com
• Cookiebot
• https://jobs.biospace.com/searchjobs/
• https://events.biospace.com/
• https://page.bsigroup.com/l/73472/2026-01-09/2cj6bmb
• https://hubs.la/Q040BT1m0
• https://eu1.hubs.ly/H0rvdSS0
• https://employer.biospace.com/login
• https://employer.biospace.com/pricing/
• https://twitter.com/biospace
• https://www.instagram.com/biospacenews/
• https://www.facebook.com/biospacecommunity
• https://www.linkedin.com/company/biospaceinc

            Domain Name: BIOSPACE.COM
Registrar: GoDaddy.com, LLC
Domain Status: client delete prohibited
Domain Status: client renew prohibited
Domain Status: client transfer prohibited
Domain Status: client update prohibited
Creation Date: 1995-01-31T05:00:00Z
Registry Expiry Date: 2031-01-06T11:59:59Z
Updated Date: 2025-12-08T17:01:59Z
Name Server: NS-1202.AWSDNS-22.ORG
Name Server: NS-152.AWSDNS-19.COM
Name Server: NS-1742.AWSDNS-25.CO.UK
Name Server: NS-943.AWSDNS-53.NET
REGISTRAR Contact: GoDaddy.com, LLC
>>> Last update of RDAP database: 2026-07-10T00:19:13Z         

			User-agent: *
Crawl-delay: 1
Disallow: /share-view
Disallow: /search
Disallow: /cms


#Sitemaps
Sitemap:  https://www.biospace.com/sitemap.xml
Sitemap:  https://www.biospace.com/news-sitemap.xml        

Techniczne SEO

SEO na stronie

Treść i UX